John Sulston (1942-2018) – Founding Director of the Wellcome Sanger Institute

We are deeply saddened to announce the death of Professor Sir John Sulston, Founding Director of the Wellcome Sanger Institute

John Sulston (1942-2018) – Founding Director of the Wellcome Sanger Institute

Professor Sir John Sulston pictured next to the Wellcome Sanger Institute's laboratory buildings that is named after him.Wellcome Sanger Institute, Genome Research Limited
Professor Sir John Sulston pictured next to the Wellcome Sanger Institute's laboratory building that is named after him.

Professor Sir John Sulston founded and directed the Sanger Institute, then Sanger Centre, from 1992 to 2000, leading a historic period of genetic discovery. He led the UK’s contribution to the draft Human Genome, a monumental effort that laid the foundations for the research that is transforming healthcare and understanding of disease today.

Throughout his career, Sir John pushed scientific boundaries and was a strong believer that science is a public good. His far-sighted vision for genomics means he leaves behind a global field firmly founded on the principles of open access and a generation of scientists influenced by his actions and values.

Professor Sir John Sulston, Nobel Prize winner and Founding Director of the Wellcome Sanger Institute, who died on Tuesday 6 March 2018
Professor Sir John Sulston, Nobel Prize winner and Founding Director of the Wellcome Sanger Institute, who died on Tuesday 6 March 2018. Image Credit: Wellcome

In 2002, Sir John was awarded the Nobel Prize in Physiology or Medicine for his contribution to the understanding of how genes control cell division and cell death in an organism. His early scientific career was spent tracing the division of cells of the adult nematode worm, C. elegans to understand how cells divide and die to create a whole organism. His findings were key to understanding how cancers develop.

In 2017, Sir John was made a Companion of Honour by the Queen in her birthday honours for his major contribution to science and society.

“John was founding Director of the Wellcome Sanger Institute (then Sanger Centre). He proposed, and led from the front, the UK contributions to the human and worm reference genomes and established the Sanger Centre and Wellcome Genome Campus in order to achieve these goals.

“He had a burning and unrelenting commitment to making genome data open to all without restriction and his leadership in this regard is in large part responsible for the free access now enjoyed.

“We all feel the loss today of a great scientific visionary and leader who made historic, landmark contributions to knowledge of the living world, and established a mission and agenda that defines 21st century science.”

Professor Sir Mike Stratton, Director of the Wellcome Sanger Institute

“John was a brilliant scientist and a wonderful, kind and principled man. His leadership was critical to the establishment of the Wellcome Sanger Institute and the Human Genome Project, one of the most important scientific endeavours of the past century.

“His dedication to free access to scientific information was the basis of the open access movement, and helped ensure that the reference human genome sequence was published openly for the benefit of all humanity. It’s just one of the ways that John’s approach set the standard for researchers everywhere.”

Jeremy Farrar, Director of Wellcome

“I am deeply saddened to hear of John’s death. His contribution to genetics was unparalleled and in setting up the Wellcome Sanger Institute he changed the course of genomics research. It was an honour to know him and sympathies go to his family.”

Eliza Manningham-Buller, Chair of Wellcome

Sir John was born on the 27 March 1942. From an early age, he was fascinated with the mechanical workings of organisms and went on to complete his undergraduate degree in organic chemistry at Pembroke College, Cambridge in 1963. He then went on to join the Department of Chemistry at the University of Cambridge, where he carried out a PhD on nucleotide chemistry.

Notes to Editors
Selected Websites
Giants in genomics: John SulstonStoriesGiants in genomics: John Sulston
Professor Sir John Sulston was the founding director of the Sanger Centre (now the Wellcome Trust Sanger Institute) from 1992 until 2000 when the ‘working draft’ of the human genome sequence was completed.

Timeline: The Human Genome ProjectFactsTimeline: The Human Genome Project
The Human Genome Project, which began officially in 1990, was the largest international collaboration ever undertaken in biology and involved thousands of scientists.

How did the Human Genome Project come about?StoriesHow did the Human Genome Project come about?
It was a project of such a huge size that no one thought it would be possible at that time, but with the support of key scientists and considerable funding, the Human Genome Project began…

Who was involved in the Human Genome Project?StoriesWho was involved in the Human Genome Project?
The Human Genome Project brought scientists together from across the globe. Worldwide collaboration and support was an essential part of the project’s success.

When was the Human Genome Project completed?StoriesWhen was the Human Genome Project completed?
In 2003, two years ahead of schedule, scientists announced that the human genome had been sequenced with an accuracy of 99.99 per cent. It was described as ‘the end of the beginning’.

Sequencing the wormStoriesSequencing the worm
The 1950s and early 1960s saw a dazzling explosion in molecular biology. The structure of DNA had been uncovered and the mysteries of biology seemed eminently solvable. What would be the next big thing?

Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7900 607793

Recent News

Wellcome Sanger Institute calls for the free movement of scientists across European borders following Brexit

The Institute has provided evidence for the UK Government Science and Technology Committee’s inquiry into an immigration system that works for science and innovation

Genomics offers new treatment options for infants with range of soft tissue tumours

Scientists uncover the genetic changes causing a group of related infant cancers

Genetic discovery will help clinicians identify aggressive versus benign bone tumours

A genetic change affecting the transcription factor, FOS is specific to osteoblastoma, distinguishing it from osteosarcoma